Cerity Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.4M | Buy |
|
|||||
|
2025
Q2 | $9.09M | Buy |
|
|||||
|
2025
Q1 | $6M | Buy |
|
|||||
|
2024
Q4 | $1.86M | Sell |
|
|||||
|
2024
Q3 | $2.2M | Buy |
|
|||||
|
2024
Q2 | $628K | Buy |
|
|||||
|
2024
Q1 | $611K | Buy |
|
|||||
|
2023
Q4 | $299K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $341K | Buy |
|
|||||
|
2023
Q1 | $362K | Buy |
|
|||||
|
2022
Q4 | $345K | Buy |
|
|||||
|
2022
Q3 | $242K | Sell |
|
|||||
|
2022
Q2 | $273K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $205K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $209K | Buy |
|
|||||
|
2019
Q1 | $215K | Sell |
|
|||||
|
2018
Q4 | $220K | Buy |
|
|||||
|
2018
Q3 | $240K | Sell |
|
|||||
|
2018
Q2 | $237K | Sell |
|
|||||
|
2018
Q1 | $369K | Sell |
|
|||||
|
2017
Q4 | $413K | Sell |
|
|||||
|
2017
Q3 | $453K | Sell |
|
|||||
|
2017
Q2 | $450K | Sell |
|
|||||
|
2017
Q1 | $648K | Buy |
|